Khellin
Drug profile
Also known as: amicardien, amicardine, amikellin, khelline, medekellin, methafrone
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Khellin is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including CYP1A1.
- Molecular targets: CYP1A1 (1 listed in DrugCentral).
- Molecular formula: C14H12O5; molecular weight 260.25 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Cytochrome P450 1A1 | CYP1A1 | unknown | Ki 5.42 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Khellin is on its molecule page.
| Molecular formula | C14H12O5 |
|---|---|
| Molecular weight | 260.25 g/mol |
| CAS number | — |
| InChIKey | HSMPDPBYAYSOBC-UHFFFAOYSA-N |
| PubChem CID | 3828 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Khellin work?
Its molecular targets in DrugCentral include CYP1A1.
What is the chemical formula of Khellin?
Khellin has the molecular formula C14H12O5 and a molecular weight of 260.25 g/mol.
Browse: all drugs starting with K · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3313 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL44746 — compound record and bioactivity
- PubChem CID 3828 — chemical identifiers
- FDA UNII 5G117T0TJZ — substance identity
- UniProt P04798 (CYP1A1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.